http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2212238-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6576e5f9d53e3a9cebfac145258ec9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dfb81fbcb188fd8d77f2654dd3be651 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_193d162d541904cf4bead337c5a00899 |
| publicationDate | 2003-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2212238-C2 |
| titleOfInvention | Method for treatment of relapsing urogenital candidiasis on background of trichomoniasis |
| abstract | FIELD: medicine, dermatovenerology. SUBSTANCE: invention proposes prescription of preparations on the first day after menses termination. Metronidazol is prescribed as an antitrichomoniasis preparation in the dose 500 mg, 3 times per 24 h, every day for one week. Orungal is prescribed as an antimycotic preparation in the dose 100 mg per 24 h, every day for one week and then in the dose 300 mg for 2 weeks. Method provides the enhancement of effectiveness of treatment, to reduce frequency of relapses of urogenital cadidiasis and to enhance indices of etiological recovery of trichomoniasis. Invention can be used in treatment of urogenital candidiasis on the background of trichomoniasis. EFFECT: enhanced effectiveness of treatment. 1 tbl |
| priorityDate | 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.